Literature DB >> 623703

Workshop on the clinical pharmacology and efficacy of mianserin.

A Coppen, H Kopera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623703      PMCID: PMC1429195     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction.

Authors:  M Nishimoto; H Hashimoto; T Ozaki; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Absolute bioavailability of mianserin tablets and solution in healthy humans.

Authors:  C J Timmer; S Pourbaix; J P Desager; M Sclavons; C Harvengt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

3.  A pharmacokinetic study of mianserin.

Authors:  K P Maguire; T R Norman; G D Burrows; B A Scoggins
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

5.  A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders.

Authors:  J P Feighner; R S Jacobs; R E Jackson; G Hendrickson; C H Merideth; P D O'Meara
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Mood, stress and longevity: convergence on ANK3.

Authors:  S Rangaraju; D F Levey; K Nho; N Jain; K D Andrews; H Le-Niculescu; D R Salomon; A J Saykin; M Petrascheck; A B Niculescu
Journal:  Mol Psychiatry       Date:  2016-05-24       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.